Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
339.11
+1.05 (0.31%)
At close: Feb 2, 2026, 4:00 PM EST
336.06
-3.05 (-0.90%)
Pre-market: Feb 3, 2026, 8:00 AM EST
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
27
Consensus Rating
Strong Buy
Price Target
$474.42
Upside
+39.90%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $495 → $408 | Hold | Maintains | $495 → $408 | +20.31% | Jan 30, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $529 → $462 | Strong Buy | Maintains | $529 → $462 | +36.24% | Jan 30, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $570 → $510 | Strong Buy | Maintains | $570 → $510 | +50.39% | Jan 30, 2026 |
| Barclays | Barclays | Buy Initiates $527 | Buy | Initiates | $527 | +55.41% | Jan 28, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $500 → $465 | Buy | Maintains | $500 → $465 | +37.12% | Jan 20, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $479 → $376 | Hold | Maintains | $479 → $376 | +10.88% | Jan 20, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $530 → $529 | Strong Buy | Maintains | $530 → $529 | +56.00% | Jan 12, 2026 |
| Needham | Needham | Strong Buy Maintains $520 → $529 | Strong Buy | Maintains | $520 → $529 | +56.00% | Jan 12, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $535 → $530 | Strong Buy | Maintains | $535 → $530 | +56.29% | Jan 8, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $370 → $351 | Hold | Maintains | $370 → $351 | +3.51% | Dec 15, 2025 |
| Stifel | Stifel | Strong Buy Maintains $495 → $508 | Strong Buy | Maintains | $495 → $508 | +49.80% | Dec 11, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $395 → $479 | Hold | Maintains | $395 → $479 | +41.25% | Nov 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $449 → $489 | Buy | Reiterates | $449 → $489 | +44.20% | Oct 31, 2025 |
| Barclays | Barclays | Buy Maintains $460 → $527 | Buy | Maintains | $460 → $527 | +55.41% | Oct 31, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $550 → $549 | Strong Buy | Maintains | $550 → $549 | +61.89% | Oct 30, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $459 → $535 | Strong Buy | Maintains | $459 → $535 | +57.77% | Oct 17, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.